Luciano J. Costa
University of Alabama at Birmingham(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, CAR-T cell therapy research, Hematopoietic Stem Cell Transplantation, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma(2019)662 cited
- → Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial(2020)660 cited
- → Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma(2023)651 cited
- → Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma(2023)646 cited
- → Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy(2019)603 cited
- → Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma(2022)599 cited
- → Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts